Related Experiment Video

Updated: Aug 6, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Response to active tuberculosis within a maternal newborn unit-military treatment facility, Alaska, April-August 2025

Amber F Britt1, Angie S Guinn1, Keith T Beam1

  • 1Epidemiology Consult Service, United States Air Force School of Aerospace Medicine, Ohio, USA.

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|July 17, 2026
PubMed

Tuberculosis (TB) disease exposure within maternity units is a significant concern due to increased risk of infection among pregnant and post-partum women and their newborns. During April-August 2025, personnel from several military health authorities were deployed to assist a military treatment facility in Alaska after a labor and delivery nurse was diagnosed with pulmonary TB disease. A total of 282 individuals were identified through contact tracing. Staff contacted the affected families, answered questions, and facilitated evaluation and treatment. 263 (92.9%) of the 283 contacts were tested. Window prophylaxis was recommended for 26 children under five years of age. Of these, 21 (80.8%) completed the full therapeutic course. Four families declined the intervention, and one child was lost to follow-up. No additional cases of TB disease were detected; however, four cases of latent TB infection were diagnosed. Standardized guidance regarding TB screening and treatment procedures including routine risk assessments, screening for healthcare workers, and window prophylaxis timelines for infants and children is imperative for prevention.

Keywords:
Case reportLabor & delivery nurseMilitary treatment facilityTuberculosis

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories: